(Q35652161)

9 August 2017

title

Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses (English)

1 reference

9 August 2017

1 reference

James K Burmester

1

1 reference

9 August 2017

Richard L Berg

2

1 reference

9 August 2017

Ingrid Glurich

3

1 reference

9 August 2017

Steven H Yale

4

1 reference

9 August 2017

John R Schmelzer

5

1 reference

9 August 2017

Michael D Caldwell

6

1 reference

9 August 2017

publication date

11 May 2011

1 reference

Clinical Medicine & Research

9 August 2017

published in

1 reference

9 August 2017

volume

9

1 reference

9 August 2017

issue

3-4

1 reference

9 August 2017

page(s)

119-124

1 reference

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Pharmacogenomics of anticoagulants: steps toward personal dosage

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Estimation of the warfarin dose with clinical and pharmacogenetic data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Understanding the pharmacogenetic approach to warfarin dosing

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

CYP4F2 genetic variant alters required warfarin dose

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Evaluation of genetic factors for warfarin dose prediction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Warfarin and the vitamin K-dependent gamma-carboxylation system

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Warfarin therapy: evolving strategies in anticoagulation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A genome-wide association study of acenocoumarol maintenance dosage.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A vitamin K epoxide reductase complex subunit 1 mutation in an Irish patient with warfarin resistance

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251364

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21562135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Warfarin pharmacogenetics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21562135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21562135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3121/CMR.2011.951

1 reference

9 August 2017

1 reference

9 August 2017

1 reference